公司資料
Viracta Therapeutics 股價、新聞與催化劑
- 股票代碼:
- VIRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for VIRX.
公司概覽
業務概覽
Viracta Therapeutics is an oncology company focused on virus-associated cancers and targeted cancer biology. Its platform aims to treat tumors linked to latent viral drivers.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Viracta sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical data, target differentiation, and the ability to build a focused oncology franchise.
生技產業定位
Viracta is a catalyst-sensitive oncology name whose stock reacts to early clinical and strategic updates.
未來催化劑
- Viracta’s catalysts are nanatinostat-based programs in EBV-positive lymphomas and any development update that keeps the antiviral-oncology story alive. The company still needs strong human data.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。